Axsome Therapeutics, Inc. Investor News: Robbins LLP is Investigating Axsome Therapeutics, Inc. (AXSM) on Behalf of Shareholders
businesswire.com
news
2022-06-01 00:00:00

June 01, 2022 06:41 PM Eastern Daylight Time SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Axsome Therapeutics, Inc. (NASDAQ: AXSM) and its officers and directors to determine whether they breached their fiduciary duties and violated securities laws in connection with its New Drug Application for AXS-07 for the acute treatment of migraine. Axsome is a biopharmaceutical company that develops novel therapies for central nervous system ("CNS") disorders in the U.
